VNDA Vanda Pharmaceuticals Forecast, Technical & Fundamental Analysis
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients... Show more
VNDA is expected to report earnings to fall 26.59% to -60 cents per share on August 05
Q2'26
Est.
$-0.60
Q1'26
Missed
by $0.13
Q4'25
Missed
by $0.83
Q3'25
Beat
by $0.05
Q2'25
Missed
by $0.17
The last earnings report on May 06 showed earnings per share of -81 cents, missing the estimate of -68 cents. With 746.88K shares outstanding, the current market capitalization sits at 360.21M.
A.I.dvisor indicates that over the last year, VNDA has been loosely correlated with IVF. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if VNDA jumps, then IVF could also see price increases.
The Moving Average Convergence Divergence (MACD) for VNDA turned positive on June 22, 2026. Looking at past instances where VNDA's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 59 cases where VNDA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on July 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VNDA as a result. In of 100 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
VNDA moved below its 50-day moving average on July 10, 2026 date and that indicates a change from an upward trend to a downward trend.
The 50-day moving average for VNDA moved below the 200-day moving average on June 26, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VNDA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
VNDA broke above its upper Bollinger Band on July 07, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for VNDA entered a downward trend on June 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. VNDA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.283) is normal, around the industry mean (22.746). P/E Ratio (126.000) is within average values for comparable stocks, (37.261). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.488). VNDA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.038). P/S Ratio (1.627) is also within normal values, averaging (432.117).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VNDA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
